Product Information
Velagliflozin is a transport inhibitor that inhibits the sodium-dependent glucose transporter 1 (SGLT1). This drug increases the excretion of glucose in the urine and reduces blood glucose levels. It can be used for the treatment of type 2 diabetes mellitus in patients with chronic kidney disease. Velagliflozin has been shown to have a long-term efficacy and to improve insulin sensitivity, which may be due to its effect on fatty acids. Velagliflozin also has a cardioprotective effect, reducing cardiac hypertrophy, cardiac fibrosis and improving heart function. The mechanism of this effect is not fully understood but it is thought that it may be due to an inhibition of pergolide mesylate, one of its metabolites.
Chemical properties
Technical inquiry about: 3D-WMB52565 Velagliflozin
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
